Publication
Article
Pharmacy Times
Mallinckrodt Pharmaceuticals Genericshas entered into a strategicalliance with Zydus Cadila's US subsidiary,Zydus Pharmaceuticals Inc.The agreement calls for MallinckrodtPharmaceuticals Generics to marketand sell products under a sharedMallinckrodt-Zypharma label. Theproducts will be developed and registeredby Zydus Pharmaceuticals andwill be manufactured by Zydus Cadilaat its US FDA-approved manufacturingplant in Ahmedabad, India.
By melding Mallinckrodt's marketingand distribution networks withZydus Cadila's product developmentand manufacturing success, Mallinckrodtexpands its product portfolio andpipeline.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.